Regen BioPharma, Inc. (RGBP)
OTCMKTS · Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
May 27, 2026, 12:14 PM EST
Regen BioPharma Employees
Regen BioPharma had 1 employees as of September 30, 2024. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$236,560
Profits / Employee
-$715,689
Market Cap
153.59K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2024 | 1 | 0 | - | 1 | 0 |
| Sep 30, 2023 | 1 | 0 | - | 1 | 0 |
| Sep 30, 2022 | 1 | -3 | -75.00% | 1 | 0 |
| Sep 30, 2018 | 4 | 0 | - | 1 | 3 |
| Sep 30, 2017 | 4 | 0 | - | 1 | 3 |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Synairgen | 34 |
| PaxMedica | 7 |
| Ampio Pharmaceuticals | 6 |
| Innovation Pharmaceuticals | 4 |
| Sigyn Therapeutics | 4 |
| GB Sciences | 2 |
Regen BioPharma News
- 7 months ago - Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc. - Accesswire
- 1 year ago - Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™ - GlobeNewsWire
- 1 year ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time - GlobeNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024 - PRNewsWire
- 2 years ago - Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024 - PRNewsWire